Familial Cancer

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Familial Cancer is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1389-9600 · 1573-7292
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
96 days received→accepted — computed from PubMed (n=95)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1792

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

81

i10-index

952

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
41%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
100898211
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Screening and Detection
Show all subjects (50)
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
  • Genomic variations and chromosomal abnormalities
  • Genomic variations and chromosomal abnormalities
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Multiple and Secondary Primary Cancers
  • Multiple and Secondary Primary Cancers
  • Family Support in Illness
  • Family Support in Illness
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Helicobacter pylori-related gastroenterology studies
  • Helicobacter pylori-related gastroenterology studies
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Colorectal and Anal Carcinomas
  • Colorectal and Anal Carcinomas
  • Prenatal Screening and Diagnostics
  • Prenatal Screening and Diagnostics
  • Nutrition, Genetics, and Disease
  • Epigenetics and DNA Methylation
  • Renal cell carcinoma treatment
  • Nutrition, Genetics, and Disease
  • Epigenetics and DNA Methylation
  • Renal cell carcinoma treatment
  • Cancer, Hypoxia, and Metabolism
  • Hedgehog Signaling Pathway Studies
  • Cancer, Hypoxia, and Metabolism
  • Hedgehog Signaling Pathway Studies
  • Neuroendocrine Tumor Research Advances
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Neuroendocrine Tumor Research Advances

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: